Regulatory Peptide Nesfatin-1 and its Relationship with Metabolic Syndrome
dc.contributor.author | Tekin, Tuba | |
dc.contributor.author | Cicek, Betul | |
dc.contributor.author | Konyaligil, Nurefsan | |
dc.date.accessioned | 2024-10-26T18:00:03Z | |
dc.date.available | 2024-10-26T18:00:03Z | |
dc.date.issued | 2019 | |
dc.department | Sivas Cumhuriyet Üniversitesi | |
dc.description.abstract | Metabolic syndrome is associated with a group of conditions abdominal obesity, high triglyceride levels, reduction in low-density lipoprotein, increased blood pressure, and increased fasting blood glucose. Hence, it poses a risk for type 2 diabetes and cardiovascular diseases. The prevalence of metabolic syndrome increases with age. Nesfatin-1. which affects different systems, has recently been discovered as a regulatory peptide molecule. With the discovery of nesfatin-1, it has been reported to inhibit the intake of nutrients and have significant regulatory effects on energy metabolism. As nesfatin-1 is present in both central and peripheral tissues, it is thought to have many functions. In addition to its suppressive effect on food intake, nesfatin-1 has also been reported to have an effect on the blood glucose level for regulating cardiac functions and affecting obesity by providing weight loss. Considering the effects of nesfatin-1, it may be associated with metabolic syndrome. | |
dc.identifier.doi | 10.5152/eurasianjmed.2019.18420 | |
dc.identifier.endpage | 284 | |
dc.identifier.issn | 1308-8734 | |
dc.identifier.issn | 1308-8742 | |
dc.identifier.issue | 3 | |
dc.identifier.pmid | 31692710 | |
dc.identifier.scopus | 2-s2.0-85075712448 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | 280 | |
dc.identifier.trdizinid | 333853 | |
dc.identifier.uri | https://doi.org/10.5152/eurasianjmed.2019.18420 | |
dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay/333853 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12418/27492 | |
dc.identifier.volume | 51 | |
dc.identifier.wos | WOS:000491164700017 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | TR-Dizin | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Aves | |
dc.relation.ispartof | Eurasian Journal of Medicine | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Metabolic syndrome | |
dc.subject | Nesfatin-1 | |
dc.subject | obesity | |
dc.subject | peptide | |
dc.title | Regulatory Peptide Nesfatin-1 and its Relationship with Metabolic Syndrome | |
dc.type | Review Article |